Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance.
about
Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis CCharacterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine In VitroReduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in Hepatitis C virus repliconInterferon gamma in successful pregnancies.Elimination of hepatitis C virus from hepatocytes by a selective activation of therapeutic molecules.Characterization of HCV interactions with Toll-like receptors and RIG-I in liver cells.Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication.The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1.Comparison of Helicobacter bilis-Associated Protein Expression in Huh7 Cells Harbouring HCV Replicon and in Replicon-Cured CellsHistone deacetylases inhibit IFN-gamma-inducible gene expression in mouse trophoblast cellsThe role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapyIdentification of alpha interferon-induced envelope mutations of hepatitis C virus in vitro associated with increased viral fitness and interferon resistance.Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C.Short-hairpin RNAs delivered by lentiviral vector transduction trigger RIG-I-mediated IFN activation.Use of HOMA-IR in hepatitis C.SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?Insulin resistance, steatosis and hepatitis C virus.Interferon-α induces G1 cell-cycle arrest in renal cell carcinoma cells via activation of Jak-Stat signaling.Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance.Anti-hepatitis C virus activity of albinterferon alfa-2b in cell culture.
P2860
Q27478298-46CD0F31-39DF-4CC1-9803-A07492ED86B9Q27480361-5557AE5B-C4B0-4A61-B22E-1F5A364DDE36Q27481650-84815555-94D9-4372-B31F-F48E8CB27809Q33770717-FA44220B-A47B-4629-A763-7D51D0186EFAQ33799276-28C1B13D-3F4A-43ED-B653-56E5988B21A8Q33939184-9B2506FF-32C7-44DE-B416-3C1D4C38A668Q34243927-B79F9C52-14E7-4EDA-8BC6-3857FE7D9186Q34655404-BCD84BB7-3ABC-4676-8328-DC10A67E9507Q36147887-1DFCCF60-D149-4D87-86CA-8A4829FDD9DFQ36425139-17E28032-27FD-4514-9031-1076AD635461Q37063664-038748EC-A052-4031-B800-B4871E2F6B76Q37336496-55A05C41-F053-4F84-B414-82FFD9A2F989Q37358617-63F446BA-A20C-4D6F-B10C-13BC39CA7603Q37406099-306D507D-2830-4721-8299-482CFC46CE66Q37931383-B0313403-34B3-47AC-AAEB-1B02CA07AA34Q38823319-CBA5266A-2871-469C-8358-BB497BE01E75Q39240971-78FF5860-3951-4D49-9DE1-331DAFF748E5Q39539208-D1FA5DCC-20C9-46EE-9971-85FB036477D0Q40119012-99B001FF-205A-4733-9707-02EBDBBC5894Q45402887-C20C321A-BEC0-4852-806C-ED458EF54C13
P2860
Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Defective Jak-Stat activation ...... C viral IFN-alpha resistance.
@en
type
label
Defective Jak-Stat activation ...... C viral IFN-alpha resistance.
@en
prefLabel
Defective Jak-Stat activation ...... C viral IFN-alpha resistance.
@en
P2093
P356
P1476
Defective Jak-Stat activation ...... C viral IFN-alpha resistance.
@en
P2093
David R Nelson
Haizhen Zhu
James M Crawford
P304
P356
10.1089/JIR.2005.25.528
P577
2005-09-01T00:00:00Z